InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,224.63
(
0.06%
)
US TECH 100
17,773.60
(
0.28%
)
Dow Jones
39,423.81
(
-0.02%
)
Brent Oil
82.18
(
-1.24%
)
Bitcoin
61,812.48
(
-1.73%
)
Post# of 1189
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MikeCr

Send PM Follow Ignore
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

MikeCr

Re: None

Tuesday, 06/27/2017 10:43:17 AM

Tuesday, June 27, 2017 10:43:17 AM

Post# of 1189
Avant Diagnostics Announces Confirmatory Clinical Utility Data for Theralink® in Pancreatic Cancer

GAITHERSBURG, Maryland, June 27, 2017 /PRNewswire/ --

- Theralink predicts 5-year survival for patients in response to standard of care

- Negative predictive value allows physicians to change treatment decisions

http://www.prnewswire.com/news-releases/avant-diagnostics-announces-confirmatory-clinical-utility-data-for-theralink-in-pancreatic-cancer-631044313.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up